The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A validated whole-blood RNA transcript-based prognostic model that predicts survival in men with castration-resistant prostate cancer.
William K. Oh
Research Funding - Source MDx
Philip Kantoff
No relevant relationships to disclose
Howard I. Scher
No relevant relationships to disclose
Jay Magidson
Research Funding - Source MDx
Karl Wassmann
Employment or Leadership Position - Source MDx
Gwo-Shu Mary Lee
No relevant relationships to disclose
Leah M. Katz
No relevant relationships to disclose
Sumit Kumar Subudhi
No relevant relationships to disclose
Aseem Anand
No relevant relationships to disclose
Martin Fleisher
No relevant relationships to disclose
Matt D. Galsky
No relevant relationships to disclose
Robert W Ross
Consultant or Advisory Role - Source MDx